About one in six Americans is currently using glucagon-like peptide-1 (GLP-1) drugs, according to a new survey.
Eleven percent of Americans are using the weight loss drugs, and another four percent have used them in the past, according to a survey from Gallup.
Three percent of respondents reported in 2024, and eight percent said in 2025, that they were currently taking GLP-1 drugs.
The drugs were first approved in the 2000s to combat diabetes.
GLP-1 is a peptide, or hormone, that is naturally produced in the small intestine.
Federal regulators approved the first GLP-1 drug for weight loss in 2021, and additional options have been cleared since then….